Patent · US Active

Vaccine generation

US11529153B2 · kind B2 · utility

0Cited by
41References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 29, 2021
Grant dateDec 20, 2022
Priority date
Expiry dateApr 29, 2041

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB01L2400/0478
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An apparatus for vaccine generation includes a syringe with a cavity that includes a solution with photosensitizers. Microbial particles are added to the solution. A light source is capable of emitting one or more wavebands of light that are effectively absorbed by the one photosensitizers to generate singlet oxygen in the solution and other radical species that rapidly react with and damage lipids, proteins, DNA, and RNA of the microbial particles. This damage produces immunogens that can be applied as a vaccine to viruses and other infectious microbial particles. A plunger that fits within a proximal opening in the syringe is used for forcing the solution including the immunogens through the filter and out of the syringe while the photosensitizers, debris and unwanted microbial particles are trapped within the filter.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.